GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (FRA:7JK) » Definitions » Cyclically Adjusted PB Ratio

EQL Pharma AB (FRA:7JK) Cyclically Adjusted PB Ratio : 16.12 (As of Jun. 24, 2024)


View and export this data going back to 2021. Start your Free Trial

What is EQL Pharma AB Cyclically Adjusted PB Ratio?

As of today (2024-06-24), EQL Pharma AB's current share price is €4.19. EQL Pharma AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €0.26. EQL Pharma AB's Cyclically Adjusted PB Ratio for today is 16.12.

The historical rank and industry rank for EQL Pharma AB's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:7JK' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 8.52   Med: 11.55   Max: 15.94
Current: 15.23

During the past years, EQL Pharma AB's highest Cyclically Adjusted PB Ratio was 15.94. The lowest was 8.52. And the median was 11.55.

FRA:7JK's Cyclically Adjusted PB Ratio is ranked worse than
95.88% of 753 companies
in the Drug Manufacturers industry
Industry Median: 1.84 vs FRA:7JK: 15.23

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

EQL Pharma AB's adjusted book value per share data for the three months ended in Mar. 2024 was €0.540. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.26 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


EQL Pharma AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for EQL Pharma AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EQL Pharma AB Cyclically Adjusted PB Ratio Chart

EQL Pharma AB Annual Data
Trend Dec14 Dec15 Dec16 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 13.23 12.83

EQL Pharma AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.23 10.06 8.75 10.60 12.83

Competitive Comparison of EQL Pharma AB's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, EQL Pharma AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EQL Pharma AB's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EQL Pharma AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where EQL Pharma AB's Cyclically Adjusted PB Ratio falls into.



EQL Pharma AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

EQL Pharma AB's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=4.19/0.26
=16.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EQL Pharma AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, EQL Pharma AB's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.54/132.2054*132.2054
=0.540

Current CPI (Mar. 2024) = 132.2054.

EQL Pharma AB Quarterly Data

Book Value per Share CPI Adj_Book
201403 0.029 99.788 0.038
201406 0.010 100.432 0.013
201409 0.062 100.161 0.082
201412 0.038 100.225 0.050
201503 0.047 99.950 0.062
201506 0.050 99.995 0.066
201509 0.060 100.228 0.079
201512 0.201 100.276 0.265
201603 0.215 100.751 0.282
201606 0.215 101.019 0.281
201609 0.209 101.138 0.273
201612 0.231 102.022 0.299
201703 0.226 102.022 0.293
201706 0.220 102.752 0.283
201709 0.228 103.279 0.292
201803 0.210 103.962 0.267
201806 0.208 104.875 0.262
201809 0.209 105.679 0.261
201812 0.265 105.912 0.331
201903 0.256 105.886 0.320
201906 0.253 106.742 0.313
201909 0.255 107.214 0.314
201912 0.265 107.766 0.325
202003 0.256 106.563 0.318
202006 0.302 107.498 0.371
202009 0.315 107.635 0.387
202012 0.330 108.296 0.403
202103 0.309 108.360 0.377
202106 0.319 108.928 0.387
202109 0.336 110.338 0.403
202112 0.392 112.486 0.461
202203 0.404 114.825 0.465
202206 0.425 118.384 0.475
202209 0.441 122.296 0.477
202212 0.471 126.365 0.493
202303 0.475 127.042 0.494
202306 0.477 129.407 0.487
202309 0.484 130.224 0.491
202312 0.532 131.912 0.533
202403 0.540 132.205 0.540

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


EQL Pharma AB  (FRA:7JK) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


EQL Pharma AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of EQL Pharma AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


EQL Pharma AB (FRA:7JK) Business Description

Traded in Other Exchanges
Address
Stortorget 1, 3rd Floor, Lund, SWE, 222 23
EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

EQL Pharma AB (FRA:7JK) Headlines

No Headlines